Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
Clinical trial NCT02442466 · TERMINATED
Trial details
- NCT number
- NCT02442466
- Sponsor
- MelCure SA
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-05-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.